labcorp america hold
labcorp america lead provid diagnost test inform servic
result mix revenu modestli lower consensu
adjust ep beat street manag rais adjust ep
guidanc headwind hit lh latter part transitori
compani done good mitig reimburs headwind well
continu volum headwind manag care contract chang
neg bp impact quarter continu believ
labcorp well posit navig volum reimburs headwind
launchpad cost save initi capit deploy harsher
impact pama take toll smaller lab maintain hold
rate rais price target base revis estim
result nutshel revenu decreas y/i
lower consensu covanc drug develop
revenu decreas bp y/i primarili due neg bp
impact foreign exchang covanc solid net book-to-bil
expand adjust oper margin bp labcorp diagnost
revenu decreas larg due neg impact divestitur
impact adjust ep higher consensu
ahead estim
labcorp diagnost lh diagnost revenu decreas
modestli estim exclud impact
divest busi test volum increas bp driven organ
growth off-set manag care contract chang one fewer
revenu day partial off-set bp better weather revenu per
requisit decreas bp adjust divestitur better
estim pama neg bp impact price
covanc covanc drug develop revenu decreas y/i
miss estim organ revenu
growth acquisit contribut fx bp
headwind exclud pass-through revenu organ revenu consist
guidanc ttm net order decreas sequenti
net order net book-to-bil declin modestli
book-to-bil covanc adjust oper margin
improv bp y/i driven organ growth acquisit
launchpad cost save partial off-set personnel cost backlog
end expect convert
revenu next month
